Pear Therapeutics

Tim Petersen

Arboretum Ventures

Tim Petersen is a Managing Director at Arboretum Ventures, a firm he co-founded in 2002. His investments primarily target medical device, health IT and services companies that redefine models for care delivery and improve access to care. Tim has led investments and held board seats for Arboretum in more than fifteen companies, including HealthMedia (acquired by Johnson & Johnson), Accuri Cytometers (acquired by BD), IntelliCyt (acquired by Sartorius) and Inogen (2014 IPO). Each of these companies generated a return of between four and ten times Arboretum’s investment. Tim currently serves on the boards of Advanced ICU Care, Concerto Health, KFx Medical, MyHealthDirect, PEAR Therapeutics and SI-BONE.

From 1999 to 2002, Tim helped establish the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. During his tenure at Michigan, he also directed the activities of the Wolverine Venture Fund, the Institute’s venture fund focused on early-stage life science and technology investments. Prior to Michigan, Tim was a manager in the investment banking practice at Plante Moran Corporate Finance and served as a management consultant at Industrial Economics, Inc.

Tim is involved in a number of community efforts focused on venture capital and entrepreneurship and has served as Chairman of the Michigan Venture Capital Association.

Tim holds a BA in Economics from Williams College, an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan.